Cargando…
Development of a Diagnostic Programmed Cell Death 1-Ligand 1 Immunohistochemistry Assay for Nivolumab Therapy in Melanoma
Nivolumab is a monoclonal antibody that blocks the interaction between programmed cell death 1 (PD1) and programmed cell death 1-ligand 1 (PD-L1), resulting in enhanced antitumor activity by the immune system. Nivolumab is currently approved by the US Food and Drug Administration (FDA) for melanoma,...
Autores principales: | Phillips, Therese, Millett, Molly M., Zhang, Xiaoling, Jansson, Malinka, Cleveland, Rachel, Simmons, Pauline, Cherryholmes, Gregory, Carnahan, Josette, William, Josette, Spaulding, Betsy, Satnick, Ilana R., Inzunza, H. David, Taylor, Clive, Cogswell, John, Novotny, James, Oroudjev, Emin, Winther, Henrik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753812/ https://www.ncbi.nlm.nih.gov/pubmed/29189265 http://dx.doi.org/10.1097/PAI.0000000000000605 |
Ejemplares similares
-
Development of an Automated PD-L1 Immunohistochemistry (IHC) Assay for Non–Small Cell Lung Cancer
por: Phillips, Therese, et al.
Publicado: (2015) -
A 10-fold and greater increase in D-dimer at admission in COVID-19 patients is highly predictive of pulmonary embolism in a retrospective cohort study
por: Perera, Adrian, et al.
Publicado: (2021) -
Next-generation Mobile Cardiac Telemetry: Clinical Value of Combining Electrocardiographic and Physiologic Parameters
por: Yoo, Dale, et al.
Publicado: (2022) -
Detection of the Vesical Arteries Using Three-dimensional Digital Subtraction Angiography Relevant to Intra-arterial Infusion Chemotherapy for Bladder Cancer Using Double-balloon Catheters
por: Yamamoto, Kiyohito, et al.
Publicado: (2023) -
Altered hemodynamics during arteriovenous fistula remodeling leads to reduced fistula patency in female mice
por: Kudze, Tambudzai, et al.
Publicado: (2020)